By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


Company News
Bay Area’s Ardelyx (ARDX) Slashes 28% of Workforce in Restructuring 8/9/2017 8:06:50 AM
Ardelyx (ARDX) Announces Date Of Second Quarter Financial Results And Presentation At Wedbush PacGrow Healthcare Conference 8/2/2017 12:35:53 PM
Ardelyx (ARDX) Reports Successful Phase III T3MPO-1 Trial Of Tenapanor In Patients With IBS-C 5/12/2017 6:36:46 AM
Ardelyx (ARDX) Reports First Quarter 2017 Operating Results And Highlights Recent Progress 5/5/2017 10:40:46 AM
Ardelyx (ARDX) Reports Clinical Progress And Fourth Quarter And Full Year 2016 Financial Results 2/20/2017 6:51:24 AM
Bay Area Biotech Ardelyx (ARDX) Rejoices as Lead Drug Hits Phase III Goals 2/15/2017 5:56:17 AM
Ardelyx (ARDX) Announces Initiation Of Two Clinical Trials For RDX7675 For Treatment Of Hyperkalemia 1/3/2017 6:53:25 AM
Ardelyx (ARDX) To Announce Third Quarter 2016 Financial Results On November 7, 2016 11/1/2016 9:21:43 AM
Ardelyx (ARDX) Strengthens Executive Leadership With The Appointment Of Reginald Seeto, MBBS, As Chief Operating Officer 10/24/2016 7:49:43 AM
Ardelyx (ARDX) To Present At Ladenburg Thalmann 2016 Healthcare Conference 9/23/2016 7:42:42 AM